Kounis retrospectively studied 488 patients with inflammatory bowel disease (IBD) who were being treated with immunomodulator therapy and reported three cases of HEV IgM-positive patients; none had a positive HEV RNA test, indicating no cases of chronic HEV infection [119]. Here, CD40LG is linked to inflammatory bowel disease.